MemPsych Biotech

Memfocus, with the novel molecule Psychlomin™ (6-MSITC), is generating revenues by addressing the crisis of declining memory, particularly among the aging.

  • Stage Product In Market
  • Industry Biotechnology
  • Location Cincinnati, OH, USA
  • Currency USD
  • Founded January 2024
  • Employees 5
  • Incorporation Type LLC
  • Website Memfocus.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free